Medicaid Ultra Brief Pulse ECT UBE Series – Ultra-Brief Pulse ECT Machine

The Medicaid Ultra Brief Pulse ECT UBE Series is an Electroconvulsive Therapy (ECT) system designed specifically for Ultra-Brief Pulse stimulation. The supplied product information specifies an ultra-brief pulse width of 0.3 ms at 800 mA current.

The UBE Series is designed around refined ECT stimulation parameters and is intended for professional clinical environments where Ultra-Brief Pulse ECT is used under appropriate medical supervision.

Product Description

Ultra-Brief Pulse ECT uses a substantially shorter electrical pulse width than conventional ECT approaches. The Medicaid UBE Series is configured with a 0.3 ms pulse width and 800 mA current.

The supplied material describes research findings reporting differences in seizure induction requirements, seizure manifestation, and cognitive effects when Ultra-Brief Pulse stimulation is compared with standard ECT. These findings should be understood as reported study observations rather than guaranteed outcomes for every patient.

✅ Key Features

• Dedicated Ultra-Brief Pulse ECT system
• 0.3 ms ultra-brief pulse width
• 800 mA current
• Designed for Ultra-Brief Pulse ECT protocols
• Refined stimulation parameters
• Designed for professional ECT clinical environments
• Intended to support controlled electrical stimulation during ECT

Ultra-Brief Pulse Stimulation

The Medicaid UBE Series provides an ultra-brief pulse width of 0.3 milliseconds (ms) at 800 mA current.

The supplied product information states that optimized ultra-brief stimulation parameters have been investigated as an alternative approach to conventional ECT stimulation.

Reported Seizure Threshold Differences

According to the supplied material, studies have reported that Ultra-Brief Pulse stimulation can be more efficient for seizure induction, with the charge at seizure threshold reported as at least three times lower than with the stimulation parameters discussed in those comparisons.

This is a study-derived claim and should not be interpreted as a guaranteed reduction for every patient or treatment protocol.

Cognitive Effects

The supplied information describes a substantial difference in cognitive effects associated with Ultra-Brief Pulse ECT.

It also reports that some patients in the referenced studies reported no noticeable memory loss after multiple Ultra-Brief Pulse ECT treatments.

Individual cognitive and memory effects can vary considerably, and clinical outcomes depend on treatment parameters, patient characteristics, treatment frequency, and other factors.

Seizure Manifestation

The supplied product information states that seizure manifestations are distinct with Ultra-Brief Pulse stimulation compared with standard ECT.

This characteristic may be relevant when clinicians assess and monitor seizure activity during treatment.

Ultra-Brief ECT vs Standard ECT

The supplied material cites studies describing the difference between Ultra-Brief ECT and standard ECT as being comparable to “day and night.”

For an objective product page, this should be treated as a reported study characterization, rather than an independent assessment or guaranteed clinical result.

Clinical Applications

The Medicaid UBE Series is intended for professional environments providing ECT, including:

• Psychiatry departments
• Psychiatric hospitals
• Mental health facilities
• Hospitals with ECT services
• Specialized ECT treatment centers

ECT should be administered only by appropriately trained medical professionals using established clinical protocols and suitable patient monitoring.

Technical Specifications